Dual Incretin Agonist 30mg — Verification Report
From Ramp Peptides · Lot TR30-02 · Tested June 2026
VialTalk
Dual Incretin Agonist 30mg
Ramp Peptides
Score
85.7
Grade
B
Good
Lot TR30-02
Tested June 2026
Report ID
8747de01
Test
Method
Result
Status
PurityFull credit
HPLC
99.83%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentPartial
Gravimetric vs label claim · tested weight not disclosed
30 mg labeled · 33.09 mg tested
Partial
EndotoxinNot submitted
Not tested
Not tested
Not submitted
Heavy metalsNot submitted
Not tested
Not tested
Not submitted
SterilityNot submitted
Not tested
Not tested
Not submitted
Batch conformityNot submitted
Not tested
Not tested
Not submitted
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/ramp-peptides/coas/8747de01-9f93-486e-bd50-dbd784ce0ec0
